Literature DB >> 8709305

Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer.

G Raviv1, T Janssen, A R Zlotta, F Descamps, A Verhest, C C Schulman.   

Abstract

PURPOSE: We attempted to characterize patients diagnosed with prostatic intraepithelial neoplasia without concurrent cancer on biopsy who had prostate cancer on subsequent biopsy.
MATERIALS AND METHODS: The records of 93 patients with low and high grade prostatic intraepithelial neoplasia without concurrent cancer on initial biopsy were analyzed. The relationships among prostatic intraepithelial neoplasia grades, patient age, digital rectal examination, serum prostate specific antigen (PSA), transrectal ultrasound appearance and final pathological results were investigated.
RESULTS: Subsequent carcinoma was found on repeat biopsy in 13.3% of patients with low grade and 47.9% with high grade prostatic intraepithelial neoplasia (p < 0.001). In the former group digital rectal examination, patient age, serum PSA and transrectal ultrasound were not predictive of cancer. Transrectal ultrasound appearance, digital rectal examination and serum PSA were statistically different between high grade prostatic intraepithelial neoplasia with and without subsequent cancer (p < 0.001, p = 0.008 and p = 0.016, respectively, univariate analysis). On multivariate analysis of patients with high grade prostatic intraepithelial neoplasia only digital rectal examination and PSA were predictive of subsequent carcinoma.
CONCLUSIONS: High grade prostatic intraepithelial neoplasia is a strong predictor of subsequent cancer, especially in men with abnormal digital rectal examination and elevated serum PSA. Patients with high grade prostatic intraepithelial neoplasia should undergo repeat biopsy to exclude cancer. Further investigations are needed to optimize the treatment of patients with low grade prostatic intraepithelial neoplasia.

Entities:  

Mesh:

Year:  1996        PMID: 8709305     DOI: 10.1016/s0022-5347(01)65699-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  20-year-old male with recurrent right flank pain.

Authors:  Ojas Shah; Brian R Matlaga; Dean G Assimos
Journal:  Rev Urol       Date:  2003

Review 2.  Biopsy standards for detection of prostate cancer.

Authors:  Bob Djavan; Markus Margreiter
Journal:  World J Urol       Date:  2007-03-07       Impact factor: 4.226

Review 3.  Precursor lesions for prostate cancer.

Authors:  M R Feneley; C Busch
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

4.  Drug therapies for eradicating high-grade prostatic intraepithelial neoplasia in the prevention of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2005

5.  Expression of myopodin induces suppression of tumor growth and metastasis.

Authors:  Ling Jing; Lijun Liu; Yan Ping Yu; Rajiv Dhir; Marie Acquafondada; Doug Landsittel; Kathleen Cieply; Alan Wells; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

6.  New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Yu-Jia Chang; Chin-Ying Chung; Shinichi Yamashita; Lei Li; Soo Ok Lee; Shuyuan Yeh; Chawnshang Chang
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

7.  The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level.

Authors:  C A Coltman
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.